Schedule 13G ownership disclosure

ACASTI PHARMA INC

Common Stock, par value $0.0001 per share · CUSIP: 00430K865

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ADAR1 Capital Management, LLC

    Shares: 1,529,200.00 · Class: 9.9%

  • ADAR1 Capital Management GP, LLC

    Shares: 1,534,254.00 · Class: 9.9%

  • Daniel Schneeberger

    Shares: 1,529,200.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-112814
Form type
SCHEDULE 13G/A
Filer
ADAR1 Capital Management, LLC
CIK
CIK 1940272
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub